Page last updated: 2024-09-03

sch 34826 and bradykinin

sch 34826 has been researched along with bradykinin in 2 studies

Compound Research Comparison

Studies
(sch 34826)
Trials
(sch 34826)
Recent Studies (post-2010)
(sch 34826)
Studies
(bradykinin)
Trials
(bradykinin)
Recent Studies (post-2010) (bradykinin)
312014,1953551,520

Protein Interaction Comparison

ProteinTaxonomysch 34826 (IC50)bradykinin (IC50)
B2 bradykinin receptorHomo sapiens (human)0.0018

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiu, PJ; Sybertz, EJ; Vemulapalli, S; Watkins, RW2

Other Studies

2 other study(ies) available for sch 34826 and bradykinin

ArticleYear
Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.
    Canadian journal of physiology and pharmacology, 1991, Volume: 69, Issue:10

    Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Desoxycorticosterone; Dioxolanes; Dipeptides; Drug Synergism; Hypertension; Iodine Radioisotopes; Kinins; Male; Metalloendopeptidases; Rats; Rats, Inbred Strains; Thiorphan

1991
Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:7

    Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Desoxycorticosterone; Dioxolanes; Dipeptides; Hypertension; Male; Methionine; Neprilysin; Rats; Rats, Inbred Strains; Sodium, Dietary

1990